{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:38Z","timestamp":1767135398213,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd004121.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000}}],"reference-count":67,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004121.pub3","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T08:45:34Z","timestamp":1397033134000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia"],"prefix":"10.1002","author":[{"given":"Shannon M","family":"Grabosch","sequence":"first","affiliation":[{"name":"Saint Louis University School of Medicine; Saint Louis University Department of Obstetrics and Gynaecology; 1025A Commodore Drive Richmond Heights Missouri USA 63117"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman M","family":"Shariff","sequence":"additional","affiliation":[{"name":"University of Louisville School of Medicine; 3646 Warner Ave Louisville Kentucky USA 40207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith L","family":"Wulff","sequence":"additional","affiliation":[{"name":"University of Louisville; Kornhauser Health Sciences Library; 500 South Preston Street Louisville KY USA 40202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. William","family":"Helm","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital; Northern Gynaecological Oncology Centre; Sheriff Hill Gateshead Tyne and Wear UK NE9 6SX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ygyno.2006.03.036","article-title":"A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical neoplasia","volume":"103","author":"Farley","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejogrb.2005.08.019","article-title":"The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III. A phase II trial","volume":"125","author":"Hefler","year":"2005","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"12","key":"10.1002\/14651858.CD004121.pub3-BIB0003|cit3","first-page":"4324","article-title":"Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study","volume":"9","author":"Ferrandina","year":"2003","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijrobp.2006.08.024","article-title":"A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment","volume":"67","author":"Herrera","year":"2006","journal-title":"International Journal of Radiation Oncology, Biology and Physics"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD004121.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/1097-0142(19951115)76:10+<1956::AID-CNCR2820761312>3.0.CO;2-V","article-title":"Chemoprevention trials and surrogate end point biomarkers in the cervix","volume":"76","author":"Mitchell","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1040-8428(02)00107-5","article-title":"Biomarkers and their use in cervical cancer chemoprevention","volume":"46","author":"Vlastos","year":"2003","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0007|cit7","unstructured":"GOG 0207: A Randomized Double-Blind Phase II Trial of Celecoxib, a COX-2 Inhibitor, in the Treatment of Patients With Cervical Intraepithelial Neoplasia 2\/3 or 3 (CIN 2\/3 or CIN 3) Ongoing study"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0008|cit8","first-page":"114","article-title":"The efficacy of 9-cis retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double blind clinical trial","volume":"12","author":"Alvarez","year":"2003","journal-title":"Cancer, Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD004121.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/LGT.0b013e3182901ef3","article-title":"Outcomes after management of young women with cervical intraepithelial neoplasia 2 with a 6-month observation protocol","volume":"18","author":"Bleecker","year":"2014","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcp.10068","article-title":"Many actions of cyclooxygenase-2 in cellular dynamics and in cancer","volume":"190","author":"Cao","year":"2002","journal-title":"Journal of Cell Physiology"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0005-2760(91)90032-D","article-title":"Prostaglandin endoperoxide synthase: regulation of enzyme expression","volume":"1083","author":"DeWitt","year":"1991","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1525-1438.2007.00798.x","article-title":"Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables","volume":"17","author":"Dursun","year":"2007","journal-title":"International Journal of Gynecological Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004121.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1002\/14651858.CD004121.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2003.10.052","article-title":"Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure","volume":"92","author":"Farley","year":"2004","journal-title":"Gynecologic Oncology"},{"issue":"12","key":"10.1002\/14651858.CD004121.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"International Journal of Cancer"},{"issue":"10","key":"10.1002\/14651858.CD004121.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bjc.6600578","article-title":"Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications","volume":"87","author":"Ferrandina","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004121.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.2002.20.4.973","article-title":"Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients","volume":"20","author":"Ferrandina","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD004121.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet-light induced skin carcinogenesis","volume":"25","author":"Fischer","year":"1999","journal-title":"Molecular Carcinogenesis"},{"issue":"11","key":"10.1002\/14651858.CD004121.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1158\/1940-6207.CAPR-11-0166","article-title":"Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer prevention","volume":"4","author":"Fischer","year":"2011","journal-title":"Cancer Prevention Research"},{"issue":"11","key":"10.1002\/14651858.CD004121.pub3-BIB0024|cit24","first-page":"3356","article-title":"A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix","volume":"7","author":"Follen","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1002\/14651858.CD004121.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0360-3016(00)01583-2","article-title":"Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy","volume":"49","author":"Gaffney","year":"2001","journal-title":"International Journal of Radiation, Oncology, Biology and Physics"},{"issue":"4","key":"10.1002\/14651858.CD004121.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0360-3016(03)00209-8","article-title":"Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy","volume":"56","author":"Gaffney","year":"2003","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD004121.pub3-BIB0028|cit28","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","article-title":"Prostaglandin synthase 2","volume":"1299","author":"Herschman","year":"1996","journal-title":"Biochimica et Biophysica Acta"},{"issue":"16","key":"10.1002\/14651858.CD004121.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","article-title":"Human cyclooxygenase-2 cDNA","volume":"89","author":"Hia","year":"1992","journal-title":"Proceedings of National Academy of Science USA"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0031|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD004121.pub3-BIB0032|cit32","first-page":"1208","article-title":"Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up regulation of interleukins 10 and down regulation of interleukins 12 production","volume":"58","author":"Huang","year":"1998","journal-title":"Cancer Research"},{"issue":"6","key":"10.1002\/14651858.CD004121.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer","volume":"90","author":"Hwang","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"10.1002\/14651858.CD004121.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"e79260","DOI":"10.1371\/journal.pone.0079260","article-title":"Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study","volume":"8","author":"Jaisamrarn","year":"2013","journal-title":"PLOS One"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0035|cit35","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis","volume":"58","author":"Kawamori","year":"1998","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4644(1996)25+<1::AID-JCB1>3.0.CO;2-4","article-title":"New agents for cancer chemoprevention","volume":"26S","author":"Kelloff","year":"1996","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.10684","article-title":"Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy","volume":"95","author":"Kim","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0090-8258(03)00224-5","article-title":"Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes","volume":"90","author":"Kim","year":"2003","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2004.09.012","article-title":"Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays","volume":"97","author":"Kim","year":"2005","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0040|cit40","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0041|cit41","first-page":"519","article-title":"Increased expression of cyclooxygenase-2 protein in human gastric carcinoma","volume":"6","author":"Lim","year":"2000","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD004121.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001318.pub2","article-title":"Surgery for cervical intraepithelial neoplasia","author":"Martin-Hirsch","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.lgt.0000236969.27502.71","article-title":"Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer","volume":"11","author":"Mitchell","year":"2007","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"22","key":"10.1002\/14651858.CD004121.pub3-BIB0045|cit45","first-page":"5647","article-title":"Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder","volume":"59","author":"Mohammed","year":"1999","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001703-200502000-00009","article-title":"COX-2: a protein with an active role in gynecological cancers","volume":"17","author":"Munkarah","year":"2005","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004121.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD004121.pub3-BIB0048|cit48","first-page":"1954","article-title":"Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment","volume":"41","author":"Narisawa","year":"1981","journal-title":"Cancer Research"},{"issue":"14","key":"10.1002\/14651858.CD004121.pub3-BIB0049|cit49","first-page":"3028","article-title":"Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine","volume":"58","author":"Okajima","year":"1998","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":"The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1245\/ASO.2004.05.027","article-title":"Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer","volume":"11","author":"Pockaj","year":"2004","journal-title":"Annals of Surgical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD004121.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJMe068158","article-title":"Risks and benefits of celecoxib to prevent recurrent adenomas","volume":"355","author":"Psaty","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004121.pub3-BIB0053|cit53","first-page":"293","article-title":"Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis","volume":"60","author":"Reddy","year":"2000","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0054|cit54","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/gyno.1999.5690","article-title":"High cyclooxygenase-2 expression in stage 1B cervical cancer with lymph node metastasis or parametrial invasion","volume":"76","author":"Ryu","year":"2000","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD004121.pub3-BIB0056|cit56","first-page":"1229","article-title":"Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the oesophagus","volume":"6","author":"Shamma","year":"2000","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.ju.0000043638.89552.ed","article-title":"Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder","volume":"169","author":"Shariat","year":"2003","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD004121.pub3-BIB0058|cit58","first-page":"2424","article-title":"Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder","volume":"6","author":"Shirahama","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"10.1002\/14651858.CD004121.pub3-BIB0059|cit59","unstructured":"Sobolewski C Cerella C Dicato M Ghibelli L Diederich M The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies International Journal of Cell Biology"},{"issue":"12","key":"10.1002\/14651858.CD004121.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B","article-title":"COX-2 is expressed in human pulmonary, colonic, and mammary tumors","volume":"89","author":"Soslow","year":"2000","journal-title":"Cancer"},{"issue":"9057","key":"10.1002\/14651858.CD004121.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","article-title":"Specific inhibition of cyclooxygenase-2 restores tumor reactivity by altering the balance of IL-10 and IL-12 synthesis","volume":"164","author":"Stolina","year":"2000","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1002\/14651858.CD004121.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02975128","article-title":"Signal transduction network leading to COX-2 induction: a road map in search of cancer chemopreventives","volume":"28","author":"Surh","year":"2005","journal-title":"Archives of Pharmacal Research"},{"issue":"5","key":"10.1002\/14651858.CD004121.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jcp.2004.021923","article-title":"Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications","volume":"58","author":"Tan","year":"2005","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"10.1002\/14651858.CD004121.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells over expressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"issue":"7","key":"10.1002\/14651858.CD004121.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","article-title":"Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential","volume":"94","author":"Tsujii","year":"1997","journal-title":"Proceedings of National Academy of Science USA"},{"issue":"5","key":"10.1002\/14651858.CD004121.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004121.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004121.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:30:31Z","timestamp":1628530231000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004121.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":67,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004121.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}